Previous Close | 1.2000 |
Open | 1.2000 |
Bid | 1.2000 x 0 |
Ask | 1.4200 x 0 |
Day's Range | 1.2000 - 1.2000 |
52 Week Range | 0.8000 - 1.4000 |
Volume | |
Avg. Volume | 3,266 |
Market Cap | 12.302M |
Beta (5Y Monthly) | 0.84 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6820 |
Earnings Date | Nov 22, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter and year ended December 31, 2021.
Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announces Medicure's 2021 Year End Results Conference Call.
Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported that Chief Financial Officer David Gurvey (CPA, CMA, B.Sc.) is resigning, effective March 25, 2022.